ZVIA Stock Forecast 2025-2026
Distance to ZVIA Price Targets
ZVIA Price Momentum
10 Quality Stocks Worth Considering Now
Researching Zevia (ZVIA) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ZVIA and similar high-potential opportunities.
Latest ZVIA Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, ZVIA has a neutral consensus with a median price target of $4.13 (ranging from $2.75 to $6.00). The overall analyst rating is Buy (7.7/10). Currently trading at $2.22, the median forecast implies a 85.8% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Dana Telsey at Telsey Advisory Group, projecting a 170.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ZVIA Analyst Ratings
ZVIA Price Target Range
Latest ZVIA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ZVIA.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Feb 27, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
Jan 14, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $4.00 |
Jan 14, 2025 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $3.75 |
Nov 7, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
Nov 4, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
May 9, 2024 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $1.00 |
May 9, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
May 9, 2024 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $1.25 |
Feb 28, 2024 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $2.00 |
Feb 21, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Reiterates | $4.00 |
Nov 8, 2023 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $3.00 |
Aug 15, 2023 | Telsey Advisory Group | Dana Telsey | Market Perform | Reiterates | $4.00 |
Aug 9, 2023 | Telsey Advisory Group | Dana Telsey | Market Perform | Reiterates | $4.00 |
Aug 9, 2023 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $5.00 |
Aug 9, 2023 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $3.25 |
Jul 25, 2023 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $3.00 |
Jul 25, 2023 | Goldman Sachs | Bonnie Herzog | Neutral | Downgrade | $3.00 |
Jul 25, 2023 | Telsey Advisory Group | Dana Telsey | Market Perform | Downgrade | $4.00 |
Jul 25, 2023 | Stephens & Co. | Ben Bienvenu | Overweight | Reiterates | $8.00 |
May 10, 2023 | Telsey Advisory Group | Dana Telsey | Outperform | Reiterates | $5.00 |
Zevia PBC (ZVIA) Competitors
The following stocks are similar to Zevia based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zevia PBC (ZVIA) Financial Data
Zevia PBC has a market capitalization of $143.26M with a P/E ratio of -6.5x. The company generates $155.05M in trailing twelve-month revenue with a -12.9% profit margin.
Revenue growth is +4.4% quarter-over-quarter, while maintaining an operating margin of -13.1% and return on equity of -45.4%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Zevia PBC (ZVIA) Business Model
About Zevia PBC
Produces zero-calorie, naturally sweetened beverages.
Zevia PBC generates revenue by producing and selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily using stevia as a sweetener. The company targets health-conscious consumers seeking healthier alternatives to traditional sugary drinks, capitalizing on the growing demand for natural and clean-label products.
Based in Los Angeles, Zevia operates in the non-alcoholic beverage industry, which is increasingly focused on health and wellness. The company's offerings are non-GMO, vegan, and gluten-free, positioning it favorably in a competitive market. Zevia's commitment to sustainable consumption and dietary preferences is reflected in its expanding distribution across supermarkets and health food stores in North America.
Company Information
Sector
Consumer Defensive
Industry
Beverages - Non-Alcoholic
Employees
108
CEO
Ms. Amy E. Taylor
Country
United States
IPO Year
2021
Website
www.zevia.comZevia PBC (ZVIA) Latest News & Analysis
Consumer staples sector shows oversold stocks, indicating potential buying opportunities for investors seeking undervalued companies.
Oversold stocks in consumer staples indicate potential bargains, signaling a chance for investors to capitalize on undervalued companies with stable demand.
Zevia PBC (NYSE:ZVIA) will host its Q4 2024 Earnings Conference Call on February 26, 2025, at 8:30 AM ET, featuring key company executives and analysts.
The Q4 2024 earnings call indicates upcoming financial insights, which can influence stock performance and investor sentiment regarding Zevia's growth and profitability.
Zevia PBC (NYSE: ZVIA) reported Q4 2024 net sales of $39.5 million, up $1.7 million year-over-year, with a gross profit margin of 49.2%, an 8.5 percentage point increase.
Zevia's Q4 2024 results show rising net sales and a significant gross profit margin increase, indicating improved financial health and potential for future growth.
Zevia (ZVIA) reported a quarterly loss of $0.07 per share, matching estimates, an improvement from a loss of $0.14 per share a year earlier.
Zevia's smaller quarterly loss indicates improved financial performance year-over-year, which could boost investor confidence and affect stock valuation positively.
Zevia to Announce Fourth Quarter and Full Year 2024 Results on Wednesday, February 26, 2025
1 month agoZevia PBC (NYSE: ZVIA) will release its Q4 and full-year 2024 financial results on February 26, 2025, before market open, followed by a conference call at 8:30 a.m. ET.
Zevia's upcoming financial results announcement and conference call could impact its stock price, offering insights into performance trends and future outlook, crucial for investment decisions.
Zevia PBC (NYSE: ZVIA) projects Q4 2024 net sales of ~$39.5 million, aligning with prior forecasts. Adjusted EBITDA loss is expected to be $3.9M to $4.2M due to increased investments.
Zevia's strong Q4 sales outlook and strategic investments indicate potential for future growth, despite expected EBITDA losses, impacting its financial stability and investor sentiment.
Frequently Asked Questions About ZVIA Stock
What is Zevia PBC's (ZVIA) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, Zevia PBC (ZVIA) has a median price target of $4.13. The highest price target is $6.00 and the lowest is $2.75.
Is ZVIA stock a good investment in 2025?
According to current analyst ratings, ZVIA has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.22. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ZVIA stock?
Wall Street analysts predict ZVIA stock could reach $4.13 in the next 12 months. This represents a 85.8% increase from the current price of $2.22. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Zevia PBC's business model?
Zevia PBC generates revenue by producing and selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily using stevia as a sweetener. The company targets health-conscious consumers seeking healthier alternatives to traditional sugary drinks, capitalizing on the growing demand for natural and clean-label products.
What is the highest forecasted price for ZVIA Zevia PBC?
The highest price target for ZVIA is $6.00 from Dana Telsey at Telsey Advisory Group, which represents a 170.3% increase from the current price of $2.22.
What is the lowest forecasted price for ZVIA Zevia PBC?
The lowest price target for ZVIA is $2.75 from at , which represents a 23.9% increase from the current price of $2.22.
What is the overall ZVIA consensus from analysts for Zevia PBC?
The overall analyst consensus for ZVIA is neutral. Out of 7 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $4.13.
How accurate are ZVIA stock price projections?
Stock price projections, including those for Zevia PBC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.